Showing results (181-190 of 325) with videos related to
Sort By:
Pageof 33
Bioorganic & Medicinal Chemistry Letters|February 4, 2023
Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2' amide-derivatives: Synthesis, biological evaluation and structural studiesArun K Ghosh, Dana Shahabi, Maya Kipfmiller, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 20, 2022
Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infectionMakoto Inada, Masahiro Ishikane, Mari Terada, et al.Nucleosides, Nucleotides & Nucleic Acids|June 18, 2004
Design, efficient synthesis, and anti-HIV activity of 4'-C-cyano- and 4'-C-ethynyl-2'-deoxy purine nucleosidesSatoru Kohgo, Kohei Yamada, Kenji Kitano, et al.Bioorganic & Medicinal Chemistry Letters|September 30, 2017
Design, synthesis, X-ray studies, and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1'-P2' ligandsArun K Ghosh, W Sean Fyvie, Margherita Brindisi, et al.Arthritis Research & Therapy|July 7, 2010
Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosisNobuyo Higashi-Kuwata, Masatoshi Jinnin, Takamitsu Makino, et al.Biochemical and Biophysical Research Communications|November 14, 2018
MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cellsShinya Endo, Nao Nishimura, Yawara Kawano, et al.Antimicrobial Agents and Chemotherapy|September 13, 2021
Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant StrainsMaria E Cilento, Aaron B Reeve, Eleftherios Michailidis, et al.Chemmedchem|November 8, 2017
Design, Synthesis, Biological Evaluation, and X-ray Studies of HIV-1 Protease Inhibitors with Modified P2' Ligands of DarunavirArun K Ghosh, W Sean Fyvie, Margherita Brindisi, et al.Journal of Virology|July 29, 2004
Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitroKenji Maeda, Hirotomo Nakata, Yasuhiro Koh, et al.Journal of Molecular Biology|July 2, 2008
Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibitionKenji Maeda, Debananda Das, Philip D Yin, et al.Pageof 33